Successful treatment of persistent Burkholderia cepacia complex bacteremia with ceftazidime-avibactam

Pranita D. Tamma*, Yunfan Fan, Yehudit Bergman, Anna C. Sick-Samuels, Alice J. Hsu, Winston Timp, Patricia J. Simner, Bonnie C. Prokesch, David E. Greenberg

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

30 Scopus citations


We report our clinical experience treating a 2-month-old infant with congenital diaphragmatic hernia who experienced prolonged bacteremia with Burkholderia cepacia complex (Bcc) despite conventional antibiotic therapy and appropriate source control measures. The infection resolved after initiation of ceftazidime-avibactam. Wholegenome sequencing revealed that the isolate most closely resembled B. contaminans and identified the mechanism of resistance that likely contributed to clinical cure with this agent. Ceftazidime-avibactam should be considered salvage therapy for Bcc infections if other treatment options have been exhausted.

Original languageAmerican English
Article numbere02213-17
JournalAntimicrobial Agents and Chemotherapy
Issue number4
StatePublished - Apr 2018
Externally publishedYes

Bibliographical note

Publisher Copyright:
© Copyright 2018 American Society for Microbiology. All Rights Reserved.


  • Bacteremia
  • Burkholderia cepacia complex
  • Ceftazidime-avibactam
  • Whole-genome sequencing


Dive into the research topics of 'Successful treatment of persistent Burkholderia cepacia complex bacteremia with ceftazidime-avibactam'. Together they form a unique fingerprint.

Cite this